Farber's Brian Wolpin, MD, MPH, will present positive results from the RASolute 302 trial showing a substantial prolongation of survival for patients with previously treated metastatic pancreatic ...

Dr. Brian Wolpin, of the Dana-Farber Cancer Institute in Boston, presented the findings Sunday at the American Society for ...

Dana-Farber Cancer Institute says the research giant is seeking to retract six studies and correct 31 others, as local scientists face “data forgery” allegations for their cancer research. This ...

The head of Dana-Farber Cancer Institute has announced her plans to step down, as her successor has been appointed to lead the world-renowned cancer center. Laurie Glimcher will step down as president ...

In a landmark first-of-its kind study detailed this week in the prestigious New England Journal of Medicine, researchers at the renowned Dana-Farber Cancer Institute in Boston describe several months ...

Numerous studies conducted by researchers at Dana-Farber Cancer Institute report progress for cancers including head and neck cancer, metastatic breast cancer and lung cancer. The results of these ...

BOSTON--(BUSINESS WIRE)--Dana-Farber Cancer Institute today announced the completion of one of the largest fundraising campaigns focused entirely on cancer, raising a record $2.5 billion. The ...